It Kills That: Cramer Won’t Recommend Pfizer 7% Yield
Jim Cramer declines to back Pfizer despite its 7% dividend, arguing the growth case isn’t clear. Pfizer sits near a 5...
Learn quick and easy ways to save money that fit into your lifestyle. Start maximizing your savings today!
28,655 articlesJim Cramer declines to back Pfizer despite its 7% dividend, arguing the growth case isn’t clear. Pfizer sits near a 5...
Ethereum outperformed XRP in July as new institutional money flowed back into ETH. Traders debate which crypto offers...
As summer approaches, markets sit near record levels while risk factors circulate. This piece outlines six actionable...
Hims & Hers announces a billion-dollar cross-border deal to expand telehealth and wellness services, signaling a bold...
IAMGOLD has rocketed higher over the past year, with a 273% gain in 12 months. The driving force is not just gold's r...
Bitcoin slid in early trading as a macro selloff collided with Deribit’s huge BTC options expiry, pushing BTC toward ...
Ethereum’s selloff tests whether the network’s neutrality-first model can shield value as leadership exits hit the Fo...
SpaceX opened its public life with a 19% first-day jump, valuing the company at more than $2 trillion. The boom shine...
A three-week ban on Anthropic's AI services by U.S. regulators ended, igniting a debate over whether the episode coul...
AD Mortgage has sent a policy letter to the FHFA raising concerns about proposed condo financing criteria changes for...
New York Governor Hochul’s decision to pause autonomous for-hire vehicle expansion outside NYC hits Waymo and Tesla’s...
Liquidity squeezes in major private credit funds put the trillion private credit boom under stress. Bitcoin could be ...